|
Canada Expands Pilot on Foreign Reviews to High-Risk Devices
Health Canada has expanded the scope of a pilot project that uses foreign drug reviews to aid in its assessment of new drug submissions to now include foreign reviews of Class III and IV devices.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives